戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  pathological decrease of the lubrication in degenerative joint disease.
2 arthritis (OA) is an age-related progressive degenerative joint disease.
3 an turnover and cartilage degradation during degenerative joint disease.
4  whereby CSA may be an effective therapy for degenerative joint disease.
5 ut not in successfully treated infections or degenerative joint disease.
6 d function, and may serve as an indicator of degenerative joint disease.
7  short stature, joint laxity and early-onset degenerative joint disease.
8  avoiding the evolution of this condition to degenerative joint disease.
9 score was also significantly associated with degenerative joint disease.
10       Osteoarthritis (OA) is the most common degenerative joint disease.
11                  Osteoarthritis is a complex degenerative joint disease.
12 e sarcopenia, cardiovascular remodeling, and degenerative joint disease.
13 of SnCs as a therapeutic target for treating degenerative joint disease.
14  the catabolic phenotype may protect against degenerative joint disease.
15 0 could modulate cartilage mineralization in degenerative joint diseases.
16 age is an early event in the pathogenesis of degenerative joint diseases.
17  resolved associated comorbidities were 6/14 degenerative joint disease, 9/10 gastroesophageal reflux
18         Osteoarthritis (OA) is a chronic and degenerative joint disease affecting more than 500 milli
19                                              Degenerative joint disease, also known as osteoarthritis
20 ism by which synovitis could develop in both degenerative joint disease and spondylarthritis.
21 al phenotype in which surviving mice acquire degenerative joint diseases and tumors in multiple organ
22                     Osteoarthritis (OA) is a degenerative joint disease, and inflammation within an a
23 Importantly, we observe no clinical signs of degenerative joint disease apart from mild, or in one ca
24 ltrating immune cells play a central role in degenerative joint disease associated with osteoarthriti
25 matory drug (NSAID) robenacoxib in cats with degenerative joint disease-associated pain (DJD-pain).
26                          Osteoarthritis is a degenerative joint disease characterized by a progressiv
27              Osteoarthritis (OA) is a common degenerative joint disease, characterized by cartilage l
28 bular joint (TMJ) disc displacement (DD) and degenerative joint disease (DJD) has never been conclusi
29 intelligence (AI) model for the screening of degenerative joint disease (DJD) using temporomandibular
30 th and without reduction (DDwR and DDwoR) to degenerative joint disease (DJD), and patient-reported o
31                   Osteoarthritis is a common degenerative joint disease for which no disease-modifyin
32 esity comorbidity in these patients included degenerative joint disease, gastroesophageal reflux dise
33 ntial biologic therapies in the treatment of degenerative joint disease in the future.
34           Such changes might mimic prevalent degenerative joint diseases in the elderly.
35        A relationship with meniscal tear and degenerative joint disease independent of effusion was a
36 eritance, coalitions also can be acquired by degenerative joint disease, inflammatory arthritis, infe
37                           As the most common degenerative joint disease, osteoarthritis (OA) contribu
38 n of Smad3 exon 8 (Smad3(ex8/ex8)) developed degenerative joint disease resembling human osteoarthrit
39 ifferentiation and results in development of degenerative joint disease resembling osteoarthritis in
40    Osteoarthritis (OA) is the most prevalent degenerative joint disease, resulting in joint pain, imp
41 ssive degradation of the cartilage matrix in degenerative joint diseases such as osteoarthritis.
42 the integrity of the cartilage matrix during degenerative joint diseases such as osteoarthritis.
43 ose released from articular cartilage during degenerative joint diseases such as osteoarthritis.
44                                 The onset of degenerative joint diseases such as post-traumatic osteo
45 y in the local treatment of inflammatory and degenerative joint disease, such as osteoarthritis and r
46                                              Degenerative joint diseases, such as arthritis, cause lo
47 rome, hypertension, gastroesophageal reflux, degenerative joint disease symptoms, type 2 diabetes mel
48                          Osteoarthritis is a degenerative joint disease that causes pain, degradation
49                     Osteoarthritis (OA) is a degenerative joint disease that involves the destruction
50                          Osteoarthritis is a degenerative joint disease that ranks among the leading
51 r targeted influence on progenitor cells for degenerative joint disease therapies.
52 a, hypoventilation, gastroesophageal reflux, degenerative joint disease, urinary incontinence, venous
53                                              Degenerative joint disease was more prevalent in the sup
54 teoarthritis (OA) is the most common chronic degenerative joint disease which causes substantial join
55                                              Degenerative joint disease, which affects one-fifth of t
56 omologous recombination leads to early onset degenerative joint disease, which is revealed by simulta
57                          Osteoarthritis is a degenerative joint disease whose molecular mechanism is
58 steoarthritis (OA) is a prevalent, heritable degenerative joint disease with a substantial public hea